| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.3B | $5.9B | $5.5B | $5.3B | $5.1B | $4.7B | $1.2B | $1.1B |
| Cost of Revenue | $3.3B | $3.0B | $2.9B | $2.8B | $2.6B | $2.6B | $2.6B | $2.1B |
| Gross Profit | $3.0B | $2.9B | $2.7B | $2.5B | $2.4B | $2.1B | $0.5B | $0.5B |
| R&D Expense | $0.5B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.4B | $1.3B | $1.2B | $1.1B | $1.2B | $1.0B | $0.3B | $0.2B |
| Net Income | $0.8B | $0.8B | $0.6B | $0.7B | $0.8B | $0.6B | $0.1B | $0.1B |
| EPS (Basic) | $3.26 | $3.09 | $2.45 | $2.56 | $3.13 | $2.44 | $0.56 | $0.24 |
| EPS (Diluted) | $3.15 | $3.00 | $2.39 | $2.48 | $2.99 | $2.35 | $0.54 | $0.23 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.7B | $19.0B | $18.1B | $16.7B | $17.3B | $15.9B | $16.7B | $16.1B |
| Current Assets | $5.5B | $4.9B | $4.1B | $2.4B | $4.3B | $2.3B | $2.8B | $2.0B |
| Cash & Equivalents | $0.5B | $0.6B | $0.4B | $0.4B | $0.6B | $0.2B | $0.2B | $0.2B |
| Total Liabilities | $13.8B | $12.4B | $11.7B | $10.6B | $11.1B | $10.2B | $11.6B | $11.5B |
| Current Liabilities | $5.1B | $4.4B | $3.8B | $2.2B | $3.9B | $2.3B | $2.8B | $1.9B |
| Stockholders' Equity | $6.9B | $6.5B | $6.3B | $6.0B | $6.2B | $5.7B | $5.1B | $4.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.7B | $1.4B | $1.2B | $1.1B | $1.4B | $1.2B | $1.3B | $0.6B |
| Investing Cash Flow | $-1.3B | $-0.9B | $-0.3B | $-1.8B | $-0.1B | $-0.2B | $-0.1B | $-7.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B |
| Financing Cash Flow | $-0.2B | $-0.2B | $0.7B | $-1.2B | $0.6B | $-1.4B | $-0.5B | $7.5B |